RT Book, Section
A1 Lerut, Toni
A1 Nafteux, Philippe
A2 Sugarbaker, David J.
A2 Bueno, Raphael
A2 Burt, Bryan M.
A2 Groth, Shawn S.
A2 Loor, Gabriel
A2 Wolf, Andrea S.
A2 Williams, Marcia
A2 Adams, Ann
SR Print(0)
ID 1170406059
T1 Surgical Approach to Esophagogastric Junction Cancers
T2 Sugarbaker’s Adult Chest Surgery, 3e
YR 2020
FD 2020
PB McGraw-Hill Education
PP New York, NY
SN 9781260026931
LK accesssurgery.mhmedical.com/content.aspx?aid=1170406059
RD 2024/04/17
AB Esophageal  cancer  is  ranked  among  the  top  10  most  common  cancers  in  the  world,  with  more  than  480,000  new  cases  diagnosed  annually.1  The  proportion  of  cases  involving  the  two  most  common  histopathologic  entities,  adenocarcinoma  and  squamous  cell  carcinoma,  is  changing.  While  the  incidence  of  adenocarcinoma  of  the  esophagus  is  rising  rapidly  in  Western  countries,  that  of  squamous  cell  carcinoma  remains  unchanged.2  The  true  incidence  of  adenocarcinoma  is  difficult  to  determine  because  cancer  of  the  esophagogastric  junction  (EGJ)  is  classified  by  some  as  a  gastric  cancer  and  by  others  as  an  esophageal  cancer  (see  Chapter  12).  This  explains,  in  part,  the  ongoing  controversy  over  which  strategy  to  follow  when  it  comes  to  surgical  approach  and  technique.